Rainbow at shoreline

The Massachusetts ME/CFS & FM Association, a 501(c)3 founded in 1985, exists to meet the needs of patients with ME (Myalgic Encephalomyelitis), CFS (Chronic Fatigue Syndrome) or FM (Fibromyalgia), their families and loved ones. The Massachusetts ME/CFS & FM Association works to educate health-care providers and the general public regarding these severely-disabling physical illnesses. We also support patients and their families and advocate for more effective treatment and research.

Our primary goal as an Association is to serve those with ME/CFS. No one interested in becoming a member will be excluded because of financial hardship.

If the $25 annual membership contribution constitutes a significant hardship, we offer Courtesy (free) and Reduced Fee ("Pay What You Can") membership.

For a Courtesy or Reduced Fee Membership, please do the following:

  1. Fill out the Membership form on our website; sign up for Courtesy Membership and check the box "I will send payment by check." Submit the form. These steps are necessary to complete the enrollment process.
  2. For a Courtesy membership: You may ignore the "Invoice" which will arrive automatically via email.
  3. For a Reduced Fee membership: Follow the steps above and then Donate what you are able to afford.

Courtesy and Reduced Fee memberships carry all the benefits and privileges of Individual membership.

Notice about names

The Massachusetts ME/CFS & FM Association would like to clarify the use of the various acronyms for Chronic Fatigue Syndrome (CFS), Chronic Fatigue & Immune Dysfunction Syndrome (CFIDS) and  Myalgic Encephalomyelitis (ME) on this site. When we generate our own articles on the illness, we will refer to it as ME/CFS, the term now generally used in the United States. When we are reporting on someone else’s report, we will use the term they use. The National Institutes of Health (NIH) and other federal agencies, including the CDC, are currently using ME/CFS. 

Massachusetts ME/CFS & FM Association changed its name in July, 2018, to reflect this consensus.